1
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): July 2, 1999
SCICLONE PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
California 0-19825 94-3116852
- ----------------- -------------------- -------------------
(State or other (Commission File No.) (IRS Employer
jurisdiction Identification No.)
of incorporation)
901 Mariner's Island Blvd.
Suite 205
San Mateo, California 94404
- ---------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (650) 358-3456
2
ITEM 5. OTHER EVENTS
On July 2, 1999, SciClone Pharmaceuticals, Inc. sold approximately 1.37
million shares of its common stock, each accompanied by a warrant to purchase
one share of common stock, in a private placement to institutional and
individual accredited investors for an aggregate purchase price of
approximately $2 million.
On July 21, 1999, SciClone Pharmaceuticals, Inc. sold approximately 2.5
million shares of its common stock, each accompanied by a warrant to purchase
one share of common stock, in a private placement to institutional investors
for an aggregate purchase price of approximately $4 million.
A copy of the press releases announcing the financings are attached as
Exhibits 99.1 and 99.2 and are incorporated herein by reference.
ITEM 7. EXHIBITS
Exhibit No. Description
- ----------- -----------
99.1 Press release dated July 6, 1999 announcing the $2
million financing.
99.2 Press release dated July 22, 1999 announcing the
$4 million financing.
2
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Date: August 3, 1999 SCICLONE PHARMACEUTICALS, INC.
By: /s/ SHAWN K. SINGH
-------------------------------------
Shawn K. Singh
Chief Administrative Officer
3
4
EXHIBIT INDEX
Exhibit No. Description
- ----------- -----------
99.1 Press release dated July 6,
1999 announcing the $2 million
financing.
99.2 Press release dated July 22,
1999 announcing the $4 million
financing.
4